Catalyst Pharmaceutical Partners Aktie
20,18
EUR
-0,53
EUR
-2,56
%
20,88
USD
-0,20
USD
-0,95
%
Catalyst Pharmaceutical Partners Aktie Analyse
21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |